title: Aurora kinase inhibition as an anticancer strategy.
authors.affiliation: Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA.
authors.forename: John F
authors.initials: JF
authors.lastname: Hilton
authors.forename: Geoffrey I
authors.initials: GI
authors.lastname: Shapiro
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D064096:Aurora Kinase A / Q000037:antagonists & inhibitors*; D001381:Azepines / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001381:Azepines; C550258:MLN 8237; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D064096:Aurora Kinase A